ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction

This publication has 45 references indexed in Scilit:

• Myocardial infarct artery patency and reocclusion rates after treatment with duteplase at the dose used in the International Study of Infarct Survival-3
  The American Journal of Cardiology, 1993
• Overview of patency as an end point of thrombolytic therapy
  The American Journal of Cardiology, 1991
• Principles and practice of coronary thrombolysis and conjunctive treatment
  The American Journal of Cardiology, 1991
• Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction
  The American Journal of Cardiology, 1990
• Effect of Intravenous Streptokinase as Compared with That of Tissue Plasminogen Activator on Left Ventricular Function after First Myocardial Infarction
  New England Journal of Medicine, 1989
• Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial Infarction
  New England Journal of Medicine, 1989
• Comparison of two dose regimens of intravenous tissue plasminogen activator for acute myocardial infarction
  The American Journal of Cardiology, 1988
• Evaluation of 2 Intravenous Thrombolytic Agents (Anisoylated Plasminogen Streptokinase Activator Complex versus Streptokinase) in Patients with Acute Myocardial Infarction
  Drugs, 1987
• Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein Thrombosis
  New England Journal of Medicine, 1986
• A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)
  New England Journal of Medicine, 1986